Application of Shenfu Qiangxin Decoction in the Treatment of Senile Chronic Heart Failure
参附强心汤治疗老年慢性心力衰竭的应用

摘要

目的 分析参附强心汤治疗老年慢性心力衰竭的应用。方法 选择我院2021年1月-2022年1月老年慢性心力衰竭患者共70例，数字表随机分2组每组35例，对照组的患者给予常规药物治疗，观察组在该基础上增加参附强心汤。比较两组逆转心力衰竭的时间、总的住院时间、治疗前后患者彩超心脏功能相关监测指标、血液流变学指标、总有效率、不良反应。结果 观察组逆转心力衰竭的时间6.21±1.24d、总的住院时间8.21±2.51d短于对照组9.56±2.91d和11.45±3.18d，P＜0.05。治疗前二组患者彩超心脏功能相关监测指标、血液流变学指标比较，P＞0.05，而治疗后两组彩超心脏功能相关监测指标、血液流变学指标均改善，而观察组彩超心脏功能相关监测指标、血液流变学指标显著优于对照组，P＜0.05。观察组总有效率高于对照组，P＜0.05。两组治疗过程不良反应未见，P＞0.05。结论 常规药物联合参附强心汤对于老年慢性心力衰竭的治疗效果确切，有利于改善患者心功能和血液流变学，提高治疗效果，安全有效。

Abstract

Objective To analyze the application of Shenfu Qiangxin Decoction in the treatment of senile chronic heart failure.
Methods A total of 70 elderly patients with chronic heart failure in our hospital from January 2021 to January 2022 were selected, and the digital table was randomly divided into 2 groups with 35 cases in each group. The patients in the control group were given conventional drug treatment, and the observation group increased on this basis. Shenfu strong heart soup. The time of reversal of heart failure, total hospitalization time, color ultrasound cardiac function-related monitoring indicators, hemorheological indicators, total effective rate, and adverse reactions were compared between the two groups before and after treatment.
Results The time of reversal of heart failure in the observation group was 6.21±1.24d, and the total hospitalization time was 8.21±2.51d, which was shorter than that in the control group, 9.56±2.91d and 11.45±3.18d, P<0.05. Before treatment, the comparison of color ultrasound cardiac function-related monitoring indexes and hemorheological indexes of the two groups of patients, P>0.05, after treatment, color ultrasound cardiac function-related monitoring indexes and hemorheological indexes of the two groups were improved, while the color ultrasound cardiac function related indexes of the observation group were improved. The monitoring indexes and hemorheology indexes were significantly better than those of the control group, P<0.05. The total effective rate of the observation group was higher than that of the control group, P<0.05. There were no adverse reactions in the two groups during treatment, P>0.05.
Conclusion   Conventional medicine combined with Shenfu Qiangxin Decoction has definite therapeutic effect on elderly chronic heart failure, which is beneficial to improve patients' cardiac function and hemorheology, improve the therapeutic effect, and is safe and effective.